[MAP (medroxyprogesterone) in the therapy of breast carcinoma].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D004357:Drug Synergism; D005260:Female; D006801:Humans; D008327:Mammography; D008525:Medroxyprogesterone / Q000008:administration & dosage*; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000188:drug therapy
D000970:Antineoplastic Agents; D008525:Medroxyprogesterone
Il MAP nella terapia del carcinoma della mammella.